Christopher Mutz, HEAD OF RARE DISEASE at ANI PHARMACEUTICALS INC (ANIP), sold 4,000 shares at $60.45 ($242K) on 2025-05-14, disclosed to the SEC on 2025-05-15.
Open-market sale of $242k ANIP by HEAD OF RARE DISEASE. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANIP | SELL | 2026-03-04 | $31K | — | Filing → |
| ANIP | SELL | 2026-02-23 | $415K | — | Filing → |
| ANIP | SELL | 2026-02-17 | $538K | — | Filing → |